Hau Bosun 4
4 · Cellular Biomedicine Group, Inc. · Filed May 22, 2018
Insider Transaction Report
Form 4
Hau Bosun
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy) (2014 Plan)
2018-05-18+4,499→ 4,784 totalExercise: $19.71From: 2019-04-26Exp: 2028-05-18→ Common Stock (4,499 underlying)
Footnotes (1)
- [F1]This option becomes exercisable and fully vests on April 26, 2019.